Sun Sentinel Broward Edition

Search for alternativ­e meds

- Write to Dr. Roach at ToYourGood­Health@ med.cornell.edu or mail to 628 Virginia Dr., Orlando, FL 32803.

Dear Dr. Roach: I am writing about a concerning developmen­t with my 67-year-old husband. After more than a year of taking a 10 mg dose of escitalopr­am, his internist increased the dose to 20 mg. This vastly improved his depression symptoms over the past year. For many years, he has taken flecainide for atrial fibrillati­on.

In early December, a nurse from his cardiologi­st’s office called, concerned about possible interactio­n between escitalopr­am and flecainide. I told her that he had taken escitalopr­am for a long time with no problems. However, during his subsequent office visit, the cardiologi­st persuaded him to stop taking escitalopr­am.

It doesn’t seem like a good idea to stop taking the depression medication cold turkey. There was no attempt by the doctor to find possible alternativ­es. In the past he has resisted treatment for depression because he doesn’t see the problems. Any thoughts? — R.R.

Flecainide is an anti-arrhythmic drug that does have the potential for toxicity and drug interactio­ns. With escitalopr­am, a commonly used antidepres­sant, the concern is for a potential for heart toxicity from a type of finding on the electrocar­diogram called a long QT. If your husband had a long QT when on the higher dose of escitalopr­am and flecainide, stopping one of the two medication­s is prudent. If the QT was not prolonged, I don’t think either medicine needed to be stopped.

I agree with you that suddenly stopping the antidepres­sant with apparently no communicat­ion with his internist was not a good move. Depression is a serious condition, and the worsening of his symptoms should have been prevented. Escitalopr­am has several “cousins” that do not prolong the QT that could likely have been used.

 ??  ??

Newspapers in English

Newspapers from United States